Gotowa bibliografia na temat „Cardioprotective”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Cardioprotective”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Cardioprotective"
Atwal, Kamail S., i Gary J. Grover. "Treatment of Myocardial Ischemia with ATP-Sensitive Potassium Channel (KATP) Openers". Current Pharmaceutical Design 2, nr 5 (październik 1996): 585–95. http://dx.doi.org/10.2174/1381612802666221004183709.
Pełny tekst źródłaGupta, I., A. Goyal, NK Singh, HN Yadav i PL Sharma. "Hemin, a heme oxygenase-1 inducer, restores the attenuated cardioprotective effect of ischemic preconditioning in isolated diabetic rat heart". Human & Experimental Toxicology 36, nr 8 (12.10.2016): 867–75. http://dx.doi.org/10.1177/0960327116673169.
Pełny tekst źródłaHuh, Joon, Garrett J. Gross, Hiroshi Nagase i Bruce T. Liang. "Protection of cardiac myocytes via δ1-opioid receptors, protein kinase C, and mitochondrial KATP channels". American Journal of Physiology-Heart and Circulatory Physiology 280, nr 1 (1.01.2001): H377—H383. http://dx.doi.org/10.1152/ajpheart.2001.280.1.h377.
Pełny tekst źródłaGross, Eric R., Jason N. Peart, Anna K. Hsu, John A. Auchampach i Garrett J. Gross. "Extending the cardioprotective window using a novel δ-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway". American Journal of Physiology-Heart and Circulatory Physiology 288, nr 6 (czerwiec 2005): H2744—H2749. http://dx.doi.org/10.1152/ajpheart.00918.2004.
Pełny tekst źródłaSchultz, Jo El J., Anna K. Hsu, Hiroshi Nagase i Garrett J. Gross. "TAN-67, a δ1-opioid receptor agonist, reduces infarct size via activation of Gi/oproteins and KATPchannels". American Journal of Physiology-Heart and Circulatory Physiology 274, nr 3 (1.03.1998): H909—H914. http://dx.doi.org/10.1152/ajpheart.1998.274.3.h909.
Pełny tekst źródłaIntachai, Kannaporn, Siriporn C. Chattipakorn, Nipon Chattipakorn i Krekwit Shinlapawittayatorn. "Revisiting the Cardioprotective Effects of Acetylcholine Receptor Activation against Myocardial Ischemia/Reperfusion Injury". International Journal of Molecular Sciences 19, nr 9 (21.08.2018): 2466. http://dx.doi.org/10.3390/ijms19092466.
Pełny tekst źródłaPyle, W. Glen, Yi Chen i Polly A. Hofmann. "Cardioprotection through a PKC-dependent decrease in myofilament ATPase". American Journal of Physiology-Heart and Circulatory Physiology 285, nr 3 (wrzesień 2003): H1220—H1228. http://dx.doi.org/10.1152/ajpheart.00076.2003.
Pełny tekst źródłaTonkovic-Capin, Marija, Garrett J. Gross, Zeljko J. Bosnjak, James S. Tweddell, Colleen M. Fitzpatrick i John E. Baker. "Delayed cardioprotection by isoflurane: role of KATP channels". American Journal of Physiology-Heart and Circulatory Physiology 283, nr 1 (1.07.2002): H61—H68. http://dx.doi.org/10.1152/ajpheart.01040.2001.
Pełny tekst źródłaZhang, Jimmy, Sergiy M. Nadtochiy, William R. Urciuoli i Paul S. Brookes. "The cardioprotective compound cloxyquin uncouples mitochondria and induces autophagy". American Journal of Physiology-Heart and Circulatory Physiology 310, nr 1 (1.01.2016): H29—H38. http://dx.doi.org/10.1152/ajpheart.00926.2014.
Pełny tekst źródłaLiu, Shu Q., Brandon J. Tefft, Derek T. Roberts, Li-Qun Zhang, Yupeng Ren, Yan Chun Li, Yong Huang, Di Zhang, Harry R. Phillips i Yu H. Wu. "Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia". American Journal of Physiology-Heart and Circulatory Physiology 303, nr 12 (15.12.2012): H1446—H1458. http://dx.doi.org/10.1152/ajpheart.00362.2012.
Pełny tekst źródłaRozprawy doktorskie na temat "Cardioprotective"
Simpkin, J. C. "Apelin : a cardioprotective adipocytokine". Thesis, University College London (University of London), 2007. http://discovery.ucl.ac.uk/1445937/.
Pełny tekst źródłaDaubney, J. "The cardioprotective mechanisms of dietary flavonoids". Thesis, Nottingham Trent University, 2015. http://irep.ntu.ac.uk/id/eprint/27927/.
Pełny tekst źródłaMuraski, John A. "The cardioprotective effects of Pim-1 kinase". Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 2007. http://wwwlib.umi.com/cr/ucsd/fullcit?p3310011.
Pełny tekst źródłaTitle from first page of PDF file (viewed September 4, 2007). Available via ProQuest Digital Dissertations. Vita. Includes bibliographical references (p. 90-103).
Hassan, Lobna Mohammed Saber Abdel. "Intracellular mechanisms of action of cardioprotective agents". Thesis, University of Sunderland, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.338350.
Pełny tekst źródłaMcCafferty, Kieran. "Novel cardioprotective strategies for the uraemic heart". Thesis, Queen Mary, University of London, 2011. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8725.
Pełny tekst źródłaPoolman, Toryn. "Investigations into the cardioprotective properties of resveratrol". Thesis, University of Leicester, 2004. http://hdl.handle.net/2381/29695.
Pełny tekst źródłaWright, Denis Matthew John, i mikewood@deakin edu au. "Potential antiarrhythmic and cardioprotective agents based on adenosine". Deakin University. School of Biological and Chemical Sciences, 1998. http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20050915.160941.
Pełny tekst źródłaSopizhenko, Nadia. "Properties of cardioprotective preparations and their antistress effect". Thesis, Київський національний університет технологій та дизайну, 2019. https://er.knutd.edu.ua/handle/123456789/13167.
Pełny tekst źródłaBarbalace, Maria Cristina <1988>. "17β-estradiol modulates cardioprotective effects of nutraceutical compounds". Doctoral thesis, Alma Mater Studiorum - Università di Bologna, 2018. http://amsdottorato.unibo.it/8526/1/Barbalace_Maria_Cristina_tesi.pdf.
Pełny tekst źródłaMaarman, Gerald Jerome. "Melatonin as a novel cardioprotective therapy in pulmonary hypertension". Doctoral thesis, University of Cape Town, 2014. http://hdl.handle.net/11427/12872.
Pełny tekst źródłaPulmonary hypertension (PH) is characterized by elevated pulmonary arterial pressure which leads to right ventricular hypertrophy and failure. The mechanism involved in the pathophysiology of the disease remains unclear but it is suggested that oxidative stress may trigger cardiovascular dysfunction associated with the disease. To date, there is no efficient therapy against PH and novel therapies are urgently needed. Melatonin is a powerful antioxidant that can confer benefit against ischemia-reperfusion injury and hypertension. We therefore hypothesised that melatonin may confer cardiovascular benefits against PH. Methods: Oxidative stress (plasma lipid peroxidation, antioxidant capacity and antioxidant enzyme activity) was assessed in healthy (n=10), in patients with PH (n=10), in Long Evans rats (n≥6) or in a rat model of PH induced 28 days after the injection of monocrotaline (MCT, 80mg/kg, subcutaneous) (n≥6). Melatonin (75ng/L, nutritional concentration), 4mg/kg or 6mg/kg (therapeutic dose) was given daily in the drinking water of rats, with the treatment started 5 days before the injection of MCT, on the day of the injection or 14 days after the injection of MCT. The development of PH was measured by assessing right ventricular hypertrophy, cardiac fibrosis, oxidative stress and cardiac function (via echocardiography and the isolated heart Langendorff perfusion model). Results: Plasma oxidative stress was increased in both patients and rats with PH compared with their respective controls. A chronic treatment with melatonin (75ng/L, 4mg/kg or 6mg/kg) starting on the day of the injection with MCT in rats with PH reduced right ventricular hypertrophy, cardiac dysfunction and plasma oxidative stress compared with control rats. Furthermore, the beneficial effect of melatonin (6mg/kg) could be observed when given as a preventive (5 days prior to the injection of MCT) or as a curative therapy (14 days after the injection of MCT). Conclusions: Our data demonstrate that chronic treatment of melatonin confers cardioprotection in a rat model of PH. As melatonin is inexpensive, safe (no reported side effects) and already available over the counter in many countries, we propose that melatonin should be considered as a novel preventive/curative therapy to limit cardiac dysfunction in patients with PH.
Książki na temat "Cardioprotective"
Kendall, Martin J. Preventing coronary artery disease: Cardioprotective therapeutics in practice. Wyd. 2. London: Martin Dunitz, 1998.
Znajdź pełny tekst źródłaM, Beale C., red. The cardioprotective role of HRT: A clinical update. New York: Parthenon Pub. Group, 1996.
Znajdź pełny tekst źródła(Germany)), Freiburg Focus on Biomeasurement (9th 1995 Freiburg im Breisgau. Pharmacological evaluation of cardioprotective substances: Experimental induction and indicators of myocardial injury and myocardial protection. Buchenbach, Germany: Gesellschaft für Erfahrungstransfer in der Biomesstechnik e.V., 1996.
Znajdź pełny tekst źródłaCardioprotection. Oxford: Oxford University Press, 2009.
Znajdź pełny tekst źródłaInternational Symposium, Calcium Antagonists in Cardiovascular Care (1991 : Basle, Switzerland), red. Verapamil-- a cardioprotective strategy: Highlights from a satellite symposium to the International Symposium, Calcium Antagonists in Cardiovascular Care, Basle, Switzerland, Feb. 13, 1991. New York, NY: Raven Health Care Communications, 1991.
Znajdź pełny tekst źródłaMinatoguchi, Shinya. Cardioprotection Against Acute Myocardial Infarction. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-15-0167-8.
Pełny tekst źródłaBaxter, G. F., i D. M. Yellon, red. Delayed Preconditioning and Adaptive Cardioprotection. Dordrecht: Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-5312-6.
Pełny tekst źródłaF, Baxter G., i Yellon Derek M, red. Delayed preconditioning and adaptive cardioprotection. Dordrecht: Kluwer Academic Publishers, 1998.
Znajdź pełny tekst źródłaMentzer, Robert M., Masafumi Kitakaze, James M. Downey i Masatsugu Hori, red. Adenosine, Cardioprotection and Its Clinical Application. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4419-8736-5.
Pełny tekst źródłaM, Mentzer Robert, red. Adenosine, cardioprotection, and its clinical application. Boston: Kluwer Academic Publishers, 1997.
Znajdź pełny tekst źródłaCzęści książek na temat "Cardioprotective"
Prasad, Abhiram, i Bernard John Gersh. "Endogenous Cardioprotective Strategies". W Management of Myocardial Reperfusion Injury, 239–60. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-84996-019-9_11.
Pełny tekst źródłaParratt, J. R. "Cardioprotective Effects of Iloprost". W Prostacyclin and Its Stable Analogue Iloprost, 301–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-71499-3_33.
Pełny tekst źródłaMcDonald, Fiona M. "Cardioprotective Effects of Prostacyclin Analogues". W Prostanoids and Drugs, 71–81. New York, NY: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4684-7938-6_10.
Pełny tekst źródłaHershko, Chaim, Gabriela Link i Abraham M. Konijn. "Cardioprotective Effect of Iron Chelators". W Iron Chelation Therapy, 77–89. Boston, MA: Springer US, 2002. http://dx.doi.org/10.1007/978-1-4615-0593-8_5.
Pełny tekst źródłaMewton, Nathan, François Roubille, Olivier Lairez, Gilles Rioufol, Meyer Elbaz, Christophe Piot i Michel Ovize. "Translating Cardioprotective Strategies into Clinical Settings". W Management of Myocardial Reperfusion Injury, 87–99. London: Springer London, 2012. http://dx.doi.org/10.1007/978-1-84996-019-9_5.
Pełny tekst źródłaKhan, Aisha Saleem. "Trees with Hepatoprotective and Cardioprotective Activities". W Medicinally Important Trees, 133–57. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56777-8_6.
Pełny tekst źródłaDe Hert, Stefan. "Perioperative Cardioprotective Strategies in Noncardiac Surgery". W Total Intravenous Anesthesia and Target Controlled Infusions, 749–61. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-47609-4_41.
Pełny tekst źródłaAlissa, Eman M., i Gordon A. Ferns. "Potential Cardioprotective Effects of Functional Foods". W Functional Foods and Dietary Supplements, 463–87. Chichester, UK: John Wiley & Sons, Ltd, 2014. http://dx.doi.org/10.1002/9781118227800.ch17.
Pełny tekst źródłaAl-Harrasi, Ahmed, Saurabh Bhatia, Tapan Behl i Deepak Kaushik. "The Cardioprotective Effects of Essential Oils". W Role of Essential Oils in the Management of COVID-19, 329–58. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003175933-23.
Pełny tekst źródłaLim, Vuanghao, Jun Jie Tan i Yoke Keong Yong. "Kalmegh (Andrographis paniculata) and Cardioprotective Mechanisms". W Ancient and Traditional Foods, Plants, Herbs and Spices used in Cardiovascular Health and Disease, 193–213. Boca Raton: CRC Press, 2023. http://dx.doi.org/10.1201/9781003220329-15.
Pełny tekst źródłaStreszczenia konferencji na temat "Cardioprotective"
Machado, Fernanda, Irene Gómez-Domínguez, Raul Hurtado-Ribeira, Diana Martin, Manuel A. Coimbra, María Dolores del Castillo i Filipe Coreta-Gomes. "Colonic Fermentation of Coffee Melanoidins and Resulting Cardioprotective Metabolites". W ICC 2023. Basel Switzerland: MDPI, 2023. http://dx.doi.org/10.3390/icc2023-14836.
Pełny tekst źródłaНгуен, Т. Х. В., Л. Ю. Лагуткина i А. А. Хамад. "USE OF PLANT-DERIVED CARDIOPROTECTIVE COMPONENTS IN COMPOUND FEED FOR STURGEON FISH". W DEVELOPMENT AND MODERN PROBLEMS OF AQUACULTURE. ООО "ДГТУ-Принт" Адресс полиграфического предприятия 344003 пл Гагарина, зд. 1, 2023. http://dx.doi.org/10.23947/aquaculture.2023.86-89.
Pełny tekst źródłaPetrović, Anica, Jovana Bradić, Marijana Andjić, Aleksandar Kočović, Jovana Novaković i Vladimir Jakovljević. "CARDIOPROTECTIVE EFFECTS OF LADY’S BEDSTRAW EXTRACT: FOCUS ON OXIDATIVE STRESS". W 2nd International Symposium on Biotechnology. Faculty of Agronomy in Čačak, University of Kragujevac, 2024. http://dx.doi.org/10.46793/sbt29.75ap.
Pełny tekst źródłaKammerer, Susanne. "No cardioprotective effect of ACE inhibitors in patients with cancer". W ACC 2024 Scientific Session, redaktor Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2024. http://dx.doi.org/10.55788/74e63393.
Pełny tekst źródłaTabima Martinez, Diana Marcela, Victor Bilan, Stevan P. Tofovic i Mark T. Gladwin. "Is Nitrite Cardioprotective In An Obese And Pulmonary Hypertensive Rat Model?" W American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4768.
Pełny tekst źródłaKisel, J., E. Ballard, S. Eui-Sik, N. Hart, S. Srivastava, P. Murphy, P. Marino, S. Kapetanakis i J. Steier. "Cardioprotective medication in Duchenne muscular dystrophy: a single-centre cohort study". W ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.455.
Pełny tekst źródłaOjha, S., S. Azimullah, H. Al Taee i MFN Meeran. "Cardioprotective effect of (-)-α-Bisabolol in animal model of myocardial infarction". W GA 2017 – Book of Abstracts. Georg Thieme Verlag KG, 2017. http://dx.doi.org/10.1055/s-0037-1608133.
Pełny tekst źródłaAhmad, Taseer, Taous Khan, Abdul Shah, Tahira Tabassum, Sultan Almedhesh, Hamdan Al shehri Al, Alasmary Yahia, Mater Mahnashi i Mohammed Alqahtani. "Cardioprotective effect of juglone on isoproterenol-induced myocardial injury in SD rats". W The 1st International E-Conference on Antioxidants in Health and Disease. Basel, Switzerland: MDPI, 2020. http://dx.doi.org/10.3390/cahd2020-08916.
Pełny tekst źródłaKisel, J., E. Ballard, E. Suh, N. Hart, S. Kapetanakis, S. Srivastava, P. Marino, P. Murphy i J. Steier. "S124 Cardioprotective medication in Duchenne muscular dystrophy: a single-centre cohort study". W British Thoracic Society Winter Meeting 2022, QEII Centre, Broad Sanctuary, Westminster, London SW1P 3EE, 23 to 25 November 2022, Programme and Abstracts. BMJ Publishing Group Ltd and British Thoracic Society, 2022. http://dx.doi.org/10.1136/thorax-2022-btsabstracts.130.
Pełny tekst źródłaXuan, Yuan, Fu Wei, Qiusheng Zheng, Ju Bao, Xu Bo i Qiusheng Zheng. "Antioxidative and cardioprotective activities of total flavonoids from Moldavian balm (Dracocephalum moldavica L.)". W 2010 International Conference on Bioinformatics and Biomedical Technology (ICBBT 2010). IEEE, 2010. http://dx.doi.org/10.1109/icbbt.2010.5478987.
Pełny tekst źródłaRaporty organizacyjne na temat "Cardioprotective"
Garlid, Anders. Mitochondrial Reactive Oxygen Species (ROS): Which ROS is Responsible for Cardioprotective Signaling? Portland State University Library, styczeń 2000. http://dx.doi.org/10.15760/etd.1640.
Pełny tekst źródłaHerzinger, Thomas. Effects of the Cardioprotective Drugs Dexrazoxane and ADR-925 on Doxorubicin Induced Ca2+ Release from the Sarcoplasmic Reticulum. Portland State University Library, styczeń 2000. http://dx.doi.org/10.15760/etd.6945.
Pełny tekst źródłaLi, Peng, i Junjun Liu. Effect of tumor necrosis factor inhibitors on the risk of adverse cardiovascular events in patients with psoriasis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, sierpień 2022. http://dx.doi.org/10.37766/inplasy2022.8.0090.
Pełny tekst źródłaTakeda, Mamoru. Neurophysiological Mechanisms Underlying the Attenuation of Nociceptive and Pathological Pain by Phytochemicals: Clinical Application as Therapeutic Agents. Progress in Neurobiology, kwiecień 2024. http://dx.doi.org/10.60124/j.pneuro.2024.10.02.
Pełny tekst źródła